✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

ANG Lifesciences India Ltd.

ANG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹40 Cr.
P/E
0.00

ANG Lifesciences India Ltd.

  • ANG Lifesciences
  • Walpar Nutritions
  • Roopa Industries

FAQs on ANG Lifesciences India Ltd. Shareprice

ANG Lifesciences has given lower returns compared to its competitors.
ANG Lifesciences has grown at ~-35.33% over the last 1yrs while peers have grown at a median rate of -21.71%

ANG Lifesciences is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of ANG Lifesciences is 0.0, while 3 year average PE is 12.91.
Also latest EV/EBITDA of ANG Lifesciences is 1390 while 3yr average is 98.29.

View FAQ's On Business

Growth Table

  • ANG Lifesciences India Ltd.
  • Walpar Nutritions
  • Roopa Industries

Balance Sheet

  • ANG Lifesciences India Ltd.
  • Walpar Nutritions
  • Roopa Industries

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • ANG Lifesciences India Ltd.
  • Walpar Nutritions
  • Roopa Industries

Cash Flow

  • ANG Lifesciences India Ltd.
  • Walpar Nutritions
  • Roopa Industries

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • ANG Lifesciences India Ltd.
  • Walpar Nutritions
  • Roopa Industries

Quarterly Results

  • ANG Lifesciences India Ltd.
  • Walpar Nutritions
  • Roopa Industries

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on ANG Lifesciences India Ltd. Financials

ANG Lifesciences balance sheet is weak and might have solvency issues

Yes, The net debt of ANG Lifesciences is increasing.
Latest net debt of ANG Lifesciences is ₹73.31 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹58.09 Crs.

The profit is oscillating.
The profit of ANG Lifesciences is -₹11.35 Crs for TTM, -₹12.41 Crs for Mar 2025 and -₹10.14 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
ANG Lifesciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech